KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $1.1 million.

  • Astrana Health's Profit After Tax fell 9432.59% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 8312.25%. This contributed to the annual value of $49.9 million for FY2024, which is 1776.27% down from last year.
  • Per Astrana Health's latest filing, its Profit After Tax stood at $1.1 million for Q3 2025, which was down 9432.59% from $10.2 million recorded in Q2 2025.
  • Astrana Health's 5-year Profit After Tax high stood at $56.3 million for Q2 2021, and its period low was -$18.2 million during Q4 2021.
  • Its 5-year average for Profit After Tax is $13.7 million, with a median of $13.2 million in 2021.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 22495.06% in 2021, then crashed by 38035.33% in 2024.
  • Quarter analysis of 5 years shows Astrana Health's Profit After Tax stood at -$18.2 million in 2021, then soared by 79.46% to -$3.7 million in 2022, then skyrocketed by 174.41% to $2.8 million in 2023, then tumbled by 380.35% to -$7.8 million in 2024, then skyrocketed by 113.85% to $1.1 million in 2025.
  • Its Profit After Tax stands at $1.1 million for Q3 2025, versus $10.2 million for Q2 2025 and $6.7 million for Q1 2025.